BioCentury
ARTICLE | Clinical News

CyPath: Phase II data

April 4, 2011 7:00 AM UTC

Top-line data from a single-blind, U.S. Phase II trial in sputum samples from 102 high-risk, heavy military veteran smokers and a control group of 26 patients already diagnosed with lung cancer but wh...